Bladder Cancer: PD-L1 Inhibitors Changing the Standard of Care
Chapter 2In this video, Elizabeth R. Plimack, MD, MS chief of the division of genitourinary medical oncology, director of genitourinary clinical research, and associate professor in the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the role PD-L1 inhibitors are starting to play in the treatment of genitourinary cancers, including several recent approvals in bladder cancer.
Genitourinary Cancers: Current Research and New Treatments
In this video, Elizabeth R. Plimack, MD, MS chief of the division of genitourinary medical oncology, director of genitourinary clinical research, and associate professor in the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses current research in genitourinary cancers, including biomarkers for response to chemotherapy among genitourinary cancers.
Bladder Cancer: The Emergence of Personalized Medicine
In this video, Elizabeth R. Plimack, MD, MS chief of the division of genitourinary medical oncology, director of genitourinary clinical research, and associate professor in the department of hematology/oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the emerging role of personalized therapy in bladder cancer care.
